Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RTS,S/AS01 dose schedules in malaria challenge
NCT03162614Phase 2Completed
- Sponsor
- GSK
- Start
- May 2017
- Primary completion
- Jul 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of RTS,S in malaria (6 arms), sponsored by GSK. Primary endpoint: Number of Subjects With at Least One Occurrence of Plasmodium Falciparum Parasitemia. Started May 2017; status: completed.
02
Drugs
RTS,S
03
Conditions
malaria
Beyond the preview
Go deeper on NCT03162614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03162614.